BRII-B Schedules 16 Jun 2026 Virtual AGM; Seeks Approval for 2025 Accounts, Board Re-election and 20% Issuance Mandate

Bulletin Express04-23

Brii Biosciences Limited (BRII-B) has circulated a proxy form outlining the resolutions to be tabled at its online annual general meeting on 16 June 2026 at 8:00 a.m. (Hong Kong time).

Key resolutions are as follows:

1. Financial Statements • Shareholders will vote on the adoption of the audited consolidated financial statements for the year ended 31 December 2025, together with the directors’ and auditor’s reports.

2. Board Composition and Remuneration • Re-election of Dr. Zhi Hong as an executive director. • Re-election of Dr. Martin J Murphy Jr and Dr. Taiyin Yang as independent non-executive directors. • Authorisation for the board to fix directors’ remuneration.

3. Auditor Appointment • Proposal to re-appoint Deloitte Touche Tohmatsu as external auditor until the next AGM and to authorise the board to determine its fees.

4. Share Capital Mandates • General mandate allowing the board to issue, allot or transfer shares— including treasury shares—up to 20% of the company’s issued share capital as of the AGM date. • Authorisation to buy back up to 10% of issued shares (excluding treasury shares). • Conditional extension of the issuance mandate by the number of shares repurchased under the buy-back authority.

The meeting will be conducted exclusively via the Vistra eVoting Portal; shareholders intending to appoint a proxy other than the chairman must provide a valid email address to Tricor Investor Services by 14 June 2026 at 8:00 a.m. Hong Kong time.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1158796205?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-23 17:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1158796205","market":"us","top_or_hot":-1,"title":"BRII-B Schedules 16 Jun 2026 Virtual AGM; Seeks Approval for 2025 Accounts, Board Re-election and 20% Issuance Mandate","media":"Bulletin Express","content":"<p>Brii Biosciences Limited (BRII-B) has circulated a proxy form outlining the resolutions to be tabled at its online annual general meeting on 16 June 2026 at 8:00 a.m. (Hong Kong time).</p>\n<p>Key resolutions are as follows:</p>\n<p>1. Financial Statements  \n   • Shareholders will vote on the adoption of the audited consolidated financial statements for the year ended 31 December 2025, together with the directors’ and auditor’s reports.</p>\n<p>2. Board Composition and Remuneration  \n   • Re-election of Dr. Zhi Hong as an executive director.  \n   • Re-election of Dr. Martin J Murphy Jr and Dr. Taiyin Yang as independent non-executive directors.  \n   • Authorisation for the board to fix directors’ remuneration.</p>\n<p>3. Auditor Appointment  \n   • Proposal to re-appoint Deloitte Touche Tohmatsu as external auditor until the next AGM and to authorise the board to determine its fees.</p>\n<p>4. Share Capital Mandates  \n   • General mandate allowing the board to issue, allot or transfer shares— including treasury shares—up to 20% of the company’s issued share capital as of the AGM date.  \n   • Authorisation to buy back up to 10% of issued shares (excluding treasury shares).  \n   • Conditional extension of the issuance mandate by the number of shares repurchased under the buy-back authority.</p>\n<p>The meeting will be conducted exclusively via the Vistra eVoting Portal; shareholders intending to appoint a proxy other than the chairman must provide a valid email address to Tricor Investor Services by 14 June 2026 at 8:00 a.m. Hong Kong time.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRII-B Schedules 16 Jun 2026 Virtual AGM; Seeks Approval for 2025 Accounts, Board Re-election and 20% Issuance Mandate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRII-B Schedules 16 Jun 2026 Virtual AGM; Seeks Approval for 2025 Accounts, Board Re-election and 20% Issuance Mandate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-23 17:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Brii Biosciences Limited (BRII-B) has circulated a proxy form outlining the resolutions to be tabled at its online annual general meeting on 16 June 2026 at 8:00 a.m. (Hong Kong time).</p>\n<p>Key resolutions are as follows:</p>\n<p>1. Financial Statements  \n   • Shareholders will vote on the adoption of the audited consolidated financial statements for the year ended 31 December 2025, together with the directors’ and auditor’s reports.</p>\n<p>2. Board Composition and Remuneration  \n   • Re-election of Dr. Zhi Hong as an executive director.  \n   • Re-election of Dr. Martin J Murphy Jr and Dr. Taiyin Yang as independent non-executive directors.  \n   • Authorisation for the board to fix directors’ remuneration.</p>\n<p>3. Auditor Appointment  \n   • Proposal to re-appoint Deloitte Touche Tohmatsu as external auditor until the next AGM and to authorise the board to determine its fees.</p>\n<p>4. Share Capital Mandates  \n   • General mandate allowing the board to issue, allot or transfer shares— including treasury shares—up to 20% of the company’s issued share capital as of the AGM date.  \n   • Authorisation to buy back up to 10% of issued shares (excluding treasury shares).  \n   • Conditional extension of the issuance mandate by the number of shares repurchased under the buy-back authority.</p>\n<p>The meeting will be conducted exclusively via the Vistra eVoting Portal; shareholders intending to appoint a proxy other than the chairman must provide a valid email address to Tricor Investor Services by 14 June 2026 at 8:00 a.m. Hong Kong time.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02137","symbol_name":"腾盛博药-B","start_time":0,"source_url":"","article_id":"1158796205","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1158796205","pubTimestamp":1776935372,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Brii Biosciences Limited (BRII-B) has circulated a proxy form outlining the resolutions to be tabled at its online annual general meeting on 16 June 2026 at 8:00 a.m. (Hong Kong time). Key...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02137":"腾盛博药-B"},"translate_title":"BRII-B安排2026年6月16日虚拟年度股东大会；寻求批准2025年账户、董事会连任和20%的发行授权","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02137":1},"content_text":"Brii Biosciences Limited (BRII-B) has circulated a proxy form outlining the resolutions to be tabled at its online annual general meeting on 16 June 2026 at 8:00 a.m. (Hong Kong time).\nKey resolutions are as follows:\n1. Financial Statements  \n   • Shareholders will vote on the adoption of the audited consolidated financial statements for the year ended 31 December 2025, together with the directors’ and auditor’s reports.\n2. Board Composition and Remuneration  \n   • Re-election of Dr. Zhi Hong as an executive director.  \n   • Re-election of Dr. Martin J Murphy Jr and Dr. Taiyin Yang as independent non-executive directors.  \n   • Authorisation for the board to fix directors’ remuneration.\n3. Auditor Appointment  \n   • Proposal to re-appoint Deloitte Touche Tohmatsu as external auditor until the next AGM and to authorise the board to determine its fees.\n4. Share Capital Mandates  \n   • General mandate allowing the board to issue, allot or transfer shares— including treasury shares—up to 20% of the company’s issued share capital as of the AGM date.  \n   • Authorisation to buy back up to 10% of issued shares (excluding treasury shares).  \n   • Conditional extension of the issuance mandate by the number of shares repurchased under the buy-back authority.\nThe meeting will be conducted exclusively via the Vistra eVoting Portal; shareholders intending to appoint a proxy other than the chairman must provide a valid email address to Tricor Investor Services by 14 June 2026 at 8:00 a.m. Hong Kong time.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1158796205","isCrawlerRequest":true}